We have investigated the mechanism by which anti-CD28 antibodies activates
IFN-gamma production by murine NK cells. These studies reveal that engageme
nt of CD28 alone by this antibody is a poor activator of this cytokine resp
onse. Effective stimulation requires simultaneous ligation of the receptor
for Fc (Fc gamma RIII, CD16) which on its own is also a poor inducer of mur
ine NK cells. The mechanism by which immobilized anti-CD28 increases IFN-ga
mma mRNA abundance involves both upregulation of transcription as well as i
nduction of mRNA stabilization. However, the elevation of transcription is
not as evident as that induced by IL-12 which, in contrast, does not induce
message stabilization. Thus ligation of CD28 in the presence of IL-12 resu
lts in a synergistic increase in production of the cytokine. Using this ass
ay we have also determined that immobilized anti-CD28 cannot induce resting
NK cells to produce IFN-gamma. In contrast, the same cells can be induced
by BCL1-C11 tumor cells that express high amounts of the CD28 ligand, B7-2.
These studies provide important insights into the ability of cells bearing
counter-receptor for CD28 to activate NK cell-cytokine production in vivo.
(C) 1999 Elsevier Science Ltd. All rights reserved.